Boditech Med Inc. | Mutual Funds
Mutual Funds that own Boditech Med Inc.
iShares Core MSCI Emerging Markets ETF
260,109
1.11%
0
0.01%
09/05/2018
DFA Emerging Markets Small Cap Series
116,248
0.5%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
69,473
0.3%
0
0%
04/30/2018
Mirae Asset TIGER Health Care ETF
32,055
0.14%
8,689
0.31%
04/30/2018
iShares III Plc - MSCI Emerging Markets Small Cap
8,228
0.04%
0
0.03%
09/05/2018
CREF Stock Account
7,673
0.03%
0
0%
03/31/2018
DFA Emerging Markets Social Core Equity Portfolio
3,424
0.02%
0
0%
04/30/2018
John Hancock II - Emerging Markets Fund
2,834
0.01%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
2,519
0.01%
0
0%
12/31/2017
iShares II Plc - MSCI AC Far East (ex-Japan) Small Cap
1,726
0.01%
0
0.04%
09/05/2018
| Address |
43 Geodudanji 1-gil
Chuncheon GA 24398
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.boditech.co.kr |
| Updated |
09/14/2018 |
| Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. Its products include iChroma II Reader, AFIAS6, iChroma Reader, Ichroma D, i-Chamber, and hemochroma PLUS. It also provides cardiac, tumor, diabetes, hormone, infection and rheumatoid arthritics tests. |
